Related Projects
- An external quality assurance program for PCR assays to quantify parasitaemia across laboratories in the Asia-Pacific region
- Developing better tools for diagnosing patients and populations at risk of primaquine induced haemolysis
- Developing new diagnostic tests for malaria
- Evaluation and prediction of the effect of combinations of antimalarial drugs
- Identifying better treatments for uncomplicated malaria
- Understanding kinetics of antigens used in rapid diagnostic tests for malaria
- Within-host malaria modelling to improve the treatment of malaria
Related Publications
- A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early P. falciparum in an induced blood-stage malaria infection study
- Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale
- Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study
- Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against clinical malaria
- Human IL-10-producing Th1 cells exhibit a molecular signature distinct from Tr1 cells in malaria
- Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection
- Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection
- Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance
- Plasmodium malariae and ovale genomes provide insights into malaria parasite evolution
- Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium Vivax Volunteer Infection Study
- Positron emission tomography and magnetic resonance imaging of the brain in experimental human malaria, a prospective cohort study
- Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
- Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission
- Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
- Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
- Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development
- Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria
- Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
- Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection
- Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
- Within-host modeling of blood-stage malaria